Arcus Biosciences RCUS
NYSE RCUS
$25.67 +0.66 (+2.62%)
As of: Sep 29, 2026 · 3:59 PM EDT

Arcus Biosciences (RCUS) EV to EBIT (2021 - 2022)

Updated

Arcus Biosciences' EV to EBIT was 11.25 in Q3 2022, up 15.1% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) EV to EBIT (2021 - 2022) Analysis & Trends

On a trailing twelve-month basis, Arcus Biosciences' EV to EBIT was -27.22 through Sep 30, 2022; for FY2021, it came in at 43.81.

  • Quarterly EV to EBIT has moved between 9.77 (Q2 2022) and 43.81 (Q4 2021) over five years.
  • Per Business Quant data, RCUS's EV to EBIT in the three quarters before Q3 2022 was 9.77 (Q2 2022), 17.52 (Q1 2022) and 43.81 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Arcus Biosciences 3.18 Bn -157.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 11.25
Jun 30, 2022 9.77
Mar 31, 2022 17.52
Dec 31, 2021 43.81
API Access

Arcus Biosciences EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=RCUS&period=max&api_key=YOUR_API_KEY